Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Journal of the National Cancer Institute
|
November 4, 1992
ras oncogene activation and occupational exposures in acute myeloid leukemia
J A Taylor, D P Sandler, C D Bloomfield, et al.
Cancer Treatment Reports
|
March 1, 1982
Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone
R A Kyle, T F Pajak, E S Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study
M R Cooper, O R McIntyre, K J Propert, et al.
Experimental Hematology
|
March 1, 1988
Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells
A L Howell, R Miller, K A Keefe, et al.
American Journal of Hematology
|
May 1, 1984
Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols
L H Brubaker, L R Wasserman, J D Goldberg, et al.
JAMA
|
July 28, 1993
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B
R B Weiss, N J Vogelzang, B A Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience
G G Cornwell, T F Pajak, S Kochwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study
R L Capizzi, R Davis, B Powell, et al.
Blood
|
November 15, 1991
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B
R O Dillman, R B Davis, M R Green, et al.
Cancer Treatment Reports
|
May 1, 1977
Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II)
R C Mills, L H Maurer, R J Forcier, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Journal of the National Cancer Institute
|
November 4, 1992
ras oncogene activation and occupational exposures in acute myeloid leukemia
J A Taylor, D P Sandler, C D Bloomfield, et al.
Cancer Treatment Reports
|
March 1, 1982
Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone
R A Kyle, T F Pajak, E S Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study
M R Cooper, O R McIntyre, K J Propert, et al.
Experimental Hematology
|
March 1, 1988
Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells
A L Howell, R Miller, K A Keefe, et al.
American Journal of Hematology
|
May 1, 1984
Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols
L H Brubaker, L R Wasserman, J D Goldberg, et al.
JAMA
|
July 28, 1993
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B
R B Weiss, N J Vogelzang, B A Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience
G G Cornwell, T F Pajak, S Kochwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study
R L Capizzi, R Davis, B Powell, et al.
Blood
|
November 15, 1991
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B
R O Dillman, R B Davis, M R Green, et al.
Cancer Treatment Reports
|
May 1, 1977
Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II)
R C Mills, L H Maurer, R J Forcier, et al.
Page
of 9